Fluvoxamine versus fluoxetine in major depressive episode: a double‐blind randomised comparison
- 9 May 2003
- journal article
- clinical trial
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 18 (5), 379-384
- https://doi.org/10.1002/hup.490
Abstract
A double‐blind, multinational study was conducted to compare the efficacy and safety of fluvoxamine and fluoxetine in outpatients with major depressive episode; 184 patients were randomised to fluvoxamine (100 mg/day) or fluoxetine (20 mg/day) for 6 weeks. Both drugs were effective and there were no statistically significant differences between them in the area under the curve of change from baseline in the Hamilton depression rating scale (HAMD) total score. However, the percentage of HAMD responders (≥ 50% decrease in HAMD total score) at week 2, the clinical global improvement severity of illness score at week 2 and the depression subscale of the irritability, depression and anxiety scale at weeks 1, 2 and 4, all showed significant advantages for fluvoxamine. During the last 2 weeks, fluvoxamine was significantly more effective in improving the HAMD sleep disturbance scale. Both drugs were well tolerated and there were no marked differences in their side effect profiles which were typical of SSRIs. Fluvoxamine and fluoxetine have similar efficacy and safety profiles in the treatment of major depressive episode; the findings of this study indicate that fluvoxamine may have a faster onset of action with respect to resolution of depressive symptoms and result in a better improvement in sleep quality. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 20 references indexed in Scilit:
- Clinically Relevant Pharmacology of Selective Serotonin Reuptake InhibitorsClinical Pharmacokinetics, 1997
- A critical review of selective serotonin reuptake inhibitor-related sexual dysfunction; incidence, possible aetiology and implications for managementJournal of Psychopharmacology, 1997
- Comparative safety and tolerability of selective serotonin reuptake inhibitorsHuman Psychopharmacology: Clinical and Experimental, 1995
- Comparing SSRIs: From chemistry to clinical choiceHuman Psychopharmacology: Clinical and Experimental, 1995
- Double‐blind multicenter comparison of fluvoxamine versus sertraline in the treatment of depressed outpatientsDepression, 1995
- The behavioural toxicity of the selective serotonin reuptake inhibitorsInternational Clinical Psychopharmacology, 1995
- The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressantsJournal of Psychopharmacology, 1994
- FluvoxamineDrugs, 1993
- Clinical Pharmacokinetics of Selective Serotonin Reuptake InhibitorsClinical Pharmacokinetics, 1993
- Pharmacological Differences of Serotonin Reuptake Inhibitors and Possible Clinical RelevanceDrugs, 1992